# Dilated Cardiomyopathy Detection Using AI and Screening With Mobile Technology (DCM-DETECT)

Study · id `cardio:ct-nct06688396` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06688396](<https://clinicaltrials.gov/study/NCT06688396>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT06688396

Browse, organ or system: Heart  
Browse, condition area: Heart failure  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 150 participants.

## Technical summary

Registry record NCT06688396. Allocation not applicable; no masking; primary purpose screening. Start 2024-12-04 (actual); primary completion 2026-12 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose screening
- Phase: Not applicable
- Enrolled: 150 participants (planned count; ClinicalTrials.gov record NCT06688396, source copy `cardio:ctgov-nct06688396-2025-01-30`, retrieved 2026-10-26)
- Started: 2024-12-04 (actual) (ClinicalTrials.gov record NCT06688396, source copy `cardio:ctgov-nct06688396-2025-01-30`, retrieved 2026-10-26)
- Primary completion: 2026-12 (anticipated) (ClinicalTrials.gov record NCT06688396, source copy `cardio:ctgov-nct06688396-2025-01-30`, retrieved 2026-10-26)
- Completion: 2026-12 (anticipated) (ClinicalTrials.gov record NCT06688396, source copy `cardio:ctgov-nct06688396-2025-01-30`, retrieved 2026-10-26)
- Countries: United States (ClinicalTrials.gov record NCT06688396, source copy `cardio:ctgov-nct06688396-2025-01-30`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06688396-2025-01-30`, retrieved 2026-10-26)

## The registry's words

- Brief title: Dilated Cardiomyopathy Detection Using AI and Screening With Mobile Technology (DCM-DETECT)
- Acronym: DCM-DETECT
- Condition: Dilated Cardiomyopathy
- Condition: Heart Failure
- Condition: Heart Disease
- Intervention (Device): Mobile 6L AI-EKG Screening
- Lead sponsor: Lancaster General Hospital
- Lead sponsor class: OTHER
- Collaborator: Mayo Clinic
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Cardiomyopathy (heart muscle disease) (`cardio:cardiomyopathy`)
- Registry condition terms include this condition: Dilated cardiomyopathy (`cardio:dilated-cardiomyopathy`)
- Registry condition terms include this condition: Heart failure (`cardio:heart-failure`)
- Registry lists this organization as a collaborator: Mayo Clinic (`cardio:org-mayo-clinic`)

## Provenance

Content hash: dbe9c97360c4274a241a77e6a6e0613ef419d3ac73cf5a7c014784649c63fac7
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
